I-Mab Strengthens Management Team Designed to Accelerate Global Pipeline Development and Transformation Towards Commercialization

- New appointments as part of the Company's strategic development plans to accelerate transformation towards commercialization - Dr. Andrew Zhu, an...

Related Keywords

Guangzhou ,Guangdong ,China ,Shanghai ,United States ,Hong Kong ,Xujiahui ,Zhejiang ,Massachusetts ,Lishui ,Beijing ,Gaithersburg ,Maryland ,San Diego ,California ,Peking ,Hangzhou ,Emilie Wu ,Andrew Zhu ,Gigi Feng ,Jingwu Zang ,Eli Lilly ,Weimin Tang ,Jielun Zhu ,Yifei Zhu ,Wei Fu ,Joan Shen ,John Long ,Company Nasdaq ,Twitter ,Commercialization Executive Council ,Nasdaq ,Yale School Of Medicine ,Steering Committee ,Corporate Governance Committee ,Cancer Center ,Professor Of Medicine At Harvard Medical School ,Harvard Medical School ,Piacente Group Inc ,Liver Cancer Research At Massachusetts ,Oncology At Memorial Sloan Kettering Cancer Center ,Columbia University ,Exchange Commission ,Jiahui International Hospital ,University Health Science Center ,Acting Chief Executive ,Scientific Advisory ,Acting Chief Executive Officer ,I Mab Biopharma ,Chief Strategy Officer ,Chief Commercial Officer ,Chief Business Officer ,Chief Financial Officer ,Liver Cancer Research ,Massachusetts General Hospital ,Trial Design ,Practice Guidelines ,Hepatobiliary Cancers ,Hepatocellular Carcinoma ,Systemic Therapy ,Advanced Hepatocellular ,Peking University Health Science Center ,Harvard Medical ,Yale New Heaven Hospital ,Yale School ,Memorial Sloan Kettering Cancer ,England Journal ,Nature Medicine ,Lancet Oncology ,Clinical Oncology ,Chief Financial ,Chief Communications ,Piacente Group ,I Mab ,